Association of early doses of diuretics and nitrates in acute heart failure with 30 days outcomes: ancillary analysis of ELISABETH study

Author:

Gorlicki Judith12,Nekrouf Célia3,Miró Òscar4,Cotter Gad15,Davison Beth15,Mebazaa Alexandre16,Simon Tabassome3,Freund Yonathan78

Affiliation:

1. Inserm UMR-S 942, MASCOT, Paris

2. Emergency Department, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Sorbonne Paris Nord, Bobigny

3. Department of Clinical Pharmacology and Clinical Research Platform Paris-Est, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Sorbonne Université, Paris, France

4. Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain

5. Momentum Research Inc., Heart Initiative, Durham, North Carolina, USA

6. Department of Anesthesiology and Intensive Care, Hôpitaux Lariboisière – Saint Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Cité

7. Emergency Department, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université

8. IMProving Emergency Care FHU, Paris, France

Abstract

Aims The optimal dose of diuretics and nitrates for acute heart failure treatment remains uncertain. This study aimed to assess the association between intravenous nitrates and loop diuretics doses within the initial 4 h of emergency department presentation and the number of days alive and out of hospital (NDAOH) through 30 days. Methods This was an ancillary study of the ELISABETH stepped-wedge cluster randomized trial that included 502 acute heart failure patients 75 years or older in 15 French emergency departments. The primary endpoint was the NDAOH at 30 days. The total dose of intravenous nitrates and loop diuretics administered in the initial 4 h were each categorized into three classes: ‘no nitrate’, ‘> 0–16’, and ‘> 16 mg’ for nitrates and ‘< 60’, ‘60’, and ‘> 60 mg’ for diuretics. Secondary endpoints included 30-day mortality, 30-day hospital readmission, and hospital length of stay in patients alive at 30 days. Generalized linear mixed models were used to examine associations with the endpoints. Results Of 502 patients, the median age was 87 years, with 59% women. The median administered dose within the initial 4 h was 16 mg (5.0; 40.0) for nitrates and 40 mg (40.0; 80.0) for diuretics. The median NDAOH at 30 days was 19 (0.0–24.0). The adjusted ratios of the NDAOH were 0.88 [95% confidence interval (CI): 0.63–1.23] and 0.76 (95% CI: 0.58–1.00) for patients that received 60 and > 60 mg, respectively, compared with patients that received 40 mg or less of diuretics. Compared with patients who did not receive nitrates, the adjusted ratios of the NDAOH were 1.17 (95% CI: 0.82–1.67) and 1.45 (95% CI: 0.90–2.33) for patients who received 1–16 and > 16 mg, respectively. There was no significant association with any of the secondary endpoints. Conclusion In this ancillary analysis, there was no significant association between different doses of diuretics and nitrates with the NDAOH at 30 days. Point estimates and CIs may suggest that the optimal doses are less than 60 mg of diuretics, and more than 16 mg of nitrates in the first 4 h.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3